NASDAQ:NXGL NexGel Q1 2026 Earnings Report $0.59 -0.02 (-3.74%) As of 11:10 AM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast NexGel EPS ResultsActual EPSN/AConsensus EPS -$0.07Beat/MissN/AOne Year Ago EPSN/ANexGel Revenue ResultsActual RevenueN/AExpected Revenue$3.91 millionBeat/MissN/AYoY Revenue GrowthN/ANexGel Announcement DetailsQuarterQ1 2026Date5/13/2026TimeAfter Market ClosesConference Call DateTuesday, May 12, 2026Conference Call Time4:30PM ETConference Call ResourcesEarnings HistoryCompany Profile NexGel Earnings HeadlinesNEXGEL Secures Strategic Financing and Regenerative Portfolio LicenseApril 24, 2026 | theglobeandmail.comNexGel Receives Nasdaq Deficiency Notice Over Bid PriceApril 24, 2026 | tipranks.comYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners guide...please take a few seconds and download it right now before your download link expires. That way, no matter what it costs in the future, you'll have a free copy on your computer.May 8 at 1:00 AM | Profits Run (Ad)NEXGEL, Inc. (NXGL) Q4 2025 Earnings Call TranscriptApril 21, 2026 | seekingalpha.comNEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ETApril 17, 2026 | globenewswire.comNEXGEL Reschedules Shareholder Update Conference Call to April 23rd at 4:30 P.M. ET to Provide Update on Celularity TransactionApril 15, 2026 | globenewswire.comSee More NexGel Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like NexGel? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NexGel and other key companies, straight to your email. Email Address About NexGelNexGel (NASDAQ:NXGL) (NASDAQ: NXGL) is a development-stage materials science company focused on the research and commercialization of advanced polymer formulations tailored for additive manufacturing and 3D printing applications. Leveraging proprietary expertise in polymer chemistry, NexGel develops high-performance materials designed to meet rigorous mechanical, thermal, and chemical resistance requirements across diverse end markets. The company’s product pipeline includes custom-engineered resins, powders and elastomeric systems optimized for a range of additive manufacturing processes, including selective laser sintering (SLS), stereolithography (SLA) and fused deposition modeling (FDM). NexGel’s materials aim to enhance part durability, surface finish and functional performance, enabling manufacturers and designers to accelerate prototyping and scale the production of complex components. Headquartered in the United States, NexGel has pursued strategic partnerships with contract manufacturers, original equipment manufacturers (OEMs) and research institutions to drive material adoption into existing industrial workflows. The company continues to expand its geographic reach and technical capabilities as it works toward broader commercial deployment of its proprietary polymer solutions.View NexGel ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Dutch Bros Q1 Earnings: The Newest Starbucks Rival Faces Its First Big Reality CheckThe AI Fear Around Datadog Stock May Have Been Completely WrongAmprius Technologies Ups the Voltage on Forward OutlookWhy Lam Research Still Looks Like a Buy After a 300% RallyIonQ Just Posted a Breakout Quarter—But 1 Problem RemainsSLB’s Tough Quarter Masks a Powerful Long-Term ShiftSuper Micro Surges Over 20% as Margins Soar, Sales Fall Short Upcoming Earnings Constellation Energy (5/11/2026)Barrick Mining (5/11/2026)Petroleo Brasileiro S.A.- Petrobras (5/11/2026)Simon Property Group (5/11/2026)SEA (5/12/2026)Cisco Systems (5/13/2026)Alibaba Group (5/13/2026)Manulife Financial (5/13/2026)Sumitomo Mitsui Financial Group (5/13/2026)Takeda Pharmaceutical (5/13/2026) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
